M&M, Lupin and JSW Energy to see some action today

13 Nov 2025 Evaluate

Mahindra & Mahindra (M&M) and Manulife have entered into an agreement to establish a 50:50 life insurance joint venture, subject to regulatory approval. This new venture will strengthen Mahindra and Manulife’s existing footprint in India and underscores their commitment to enhancing the financial wellbeing of customers in one of the world’s fastest-growing markets. The vision is to be the number one life insurance company for rural and semi-urban India, and in serving urban customers through leadership in protection solutions.

Lupin has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Chhatrapati Sambhajinagar (Aurangabad) facility, following a product-specific Pre-Approval Inspection from September 1, 2025 to September 5, 2025. This underscores the company’s commitment to upholding the highest standards of quality and compliance, and delivering trusted healthcare solutions to patients worldwide.

JSW Energy has raised Rs 250 crore through the allotment of 25,000 Unsecured, Listed, Rated, Taxable, Redeemable Non-Convertible Debentures (NCDs) bearing a face value of Rs 1,00,000 each, on a private placement basis. The Finance Committee, at its meeting held on November 12, 2025, has allotted the same.

Omaxe has planned to acquire the 100% equity shareholding of Next10 Realbuild and Next10 Land Developers (collectively referred to as the ‘Target Companies’). Further, upon completion of the above acquisitions, the Target Companies shall become Wholly Owned Subsidiaries of Omaxe. The Target Companies belongs to Real Estate Industry.

Mukka Proteins has received approval for to make a strategic investment in United Gulf Fishery Products LLC (the Investee Company) by acquiring and/or subscribing to the shares for an amount not exceeding Rs 1 crore equivalent to 68% of the capital of the Investee Company in one or more tranches. The Board of Directors of the company at its meeting held on November 12, 2025, has approved the same.

Sansera Engineering has received approval for additional investment of Rs 30 crore in MMRFIC Technology (MMRFIC). The Board of Directors of the company at its meeting held on November 12, 2025, has approved the same.

Auro Laboratories has successfully completed World Health Organization (WHO) inspection at its Active Pharmaceutical Ingredients (API) (Bulk Drugs) manufacturing located in MIDC Tarapur, Maharashtra. The Company has received World Health Organization - Good Manufacturing Practices (WHO - GMP) Certificate from the Food & Drug Administration, Maharashtra and is valid upto September 30, 2028.

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.